Fulgent Genetics (FLGT) Other Operating Expenses (2015 - 2026)

Fulgent Genetics has disclosed Other Operating Expenses across 12 years of filings, most recently posting -$24.5 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at -$24.5 million, down 79.09% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.2 million (up 12.87% YoY), and the FY2025 annual result was $49.9 million, up 12.87% from the prior year.
• Other Operating Expenses came in at -$24.5 million for Q1 2026 at Fulgent Genetics, down from $11.5 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $132.7 million in Q4 2023 to a low of -$24.5 million in Q1 2026.
• The 5-year median for Other Operating Expenses is $10.6 million (2024), against an average of $9.8 million.
• Across the five-year window, Other Operating Expenses surged 656.78% in 2023 and sank 224.66% in 2025, its largest moves.
• Fulgent Genetics' Other Operating Expenses stood at -$23.8 million in 2022, then soared by 656.78% to $132.7 million in 2023, then sank by 91.31% to $11.5 million in 2024, then declined by 0.23% to $11.5 million in 2025, then tumbled by 313.06% to -$24.5 million in 2026.
• The last three Other Operating Expenses figures came in at -$24.5 million (Q1 2026), $11.5 million (Q4 2025), and -$6.5 million (Q3 2025), per Business Quant data.